KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,641.00
-1.00 (-0.06%)
Apr 17, 2026, 3:30 PM JST
KYORIN Pharmaceutical Market Cap
KYORIN Pharmaceutical has a market cap or net worth of 94.27 billion as of April 17, 2026. Its market cap has increased by 3.59% in one year.
Market Cap
94.27B
Enterprise Value
105.84B
Revenue
133.26B
Ranking
n/a
PE Ratio
8.76
Stock Price
1,641.00
Market Cap Chart
Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 94.27B, an increase of 416.71%. That is a compound annual growth rate of 8.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 94.27B | 6.76% |
| Dec 30, 2025 | 88.30B | 2.13% |
| Dec 30, 2024 | 86.46B | -15.45% |
| Dec 29, 2023 | 102.26B | 3.75% |
| Dec 30, 2022 | 98.56B | -6.82% |
| Dec 30, 2021 | 105.78B | -4.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 256.61B |
| Towa Pharmaceutical | 216.85B |
| Kissei Pharmaceutical | 199.59B |
| Kaken Pharmaceutical | 159.62B |
| Mochida Pharmaceutical | 128.33B |
| Zeria Pharmaceutical | 99.17B |
| ASKA Pharmaceutical Holdings | 77.29B |
| Fuji Pharma | 63.88B |